Strategic Financial Concepts LLC Purchases Shares of 10,397 iShares Biotechnology ETF (NASDAQ:IBB)

Strategic Financial Concepts LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 10,397 shares of the financial services provider’s stock, valued at approximately $1,375,000.

Other institutional investors also recently modified their holdings of the company. Chicago Partners Investment Group LLC increased its position in iShares Biotechnology ETF by 2.5% during the 4th quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock valued at $510,000 after purchasing an additional 94 shares during the period. Capital Investment Advisors LLC lifted its position in shares of iShares Biotechnology ETF by 1.0% in the 4th quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after purchasing an additional 99 shares during the period. Magnus Financial Group LLC raised its stake in iShares Biotechnology ETF by 0.8% in the fourth quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock worth $1,714,000 after buying an additional 104 shares in the last quarter. Daiwa Securities Group Inc. raised its stake in iShares Biotechnology ETF by 12.0% in the third quarter. Daiwa Securities Group Inc. now owns 1,028 shares of the financial services provider’s stock worth $150,000 after buying an additional 110 shares in the last quarter. Finally, Aptus Capital Advisors LLC lifted its holdings in iShares Biotechnology ETF by 36.5% in the third quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after buying an additional 114 shares during the period. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 0.4 %

IBB stock opened at $137.11 on Wednesday. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The business’s 50 day moving average price is $135.55 and its two-hundred day moving average price is $140.81.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.